Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Coukos

Showing results (51-60 of 355) with videos related to

Pageof 36
Sort By:
RNA Biology|August 19, 2008
Ultraconserved elements: genomics, function and diseaseEirini Baira, Joel Greshock, George Coukos, et al.
Nature Reviews. Cancer|September 15, 2022
Immunobiology of high-grade serous ovarian cancer: lessons for clinical translationLana E Kandalaft, Denarda Dangaj Laniti, George Coukos
Journal of Translational Medicine|August 7, 2012
A phase I clinical trial of adoptive transfer of folate receptor-alpha redirected autologous T cells for recurrent ovarian cancerLana E Kandalaft, Daniel J Powell, George Coukos
International Reviews of Immunology|May 12, 2011
Adjuvants for enhancing the immunogenicity of whole tumor cell vaccinesCheryl Lai-Lai Chiang, Lana E Kandalaft, George Coukos
ACS Sensors|January 10, 2022
High-Throughput Single-Cell TCR-pMHC Dissociation Rate Measurements Performed by an Autonomous Microfluidic Cellular Processing UnitFabien Jammes, Julien Schmidt, George Coukos, et al.
Cancer Cell|January 11, 2022
A roadmap for driving CAR T cells toward the oncogenic immunopeptidomeMelita Irving, Vincent Zoete, Michal Bassani-Sternberg, et al.
Vaccines|September 8, 2015
Whole Tumor Antigen Vaccines: Where Are We?Cheryl Lai-Lai Chiang, George Coukos, Lana E Kandalaft
Annals of Translational Medicine|August 27, 2016
Neoantigen-based cancer immunotherapySara Bobisse, Periklis G Foukas, George Coukos, et al.
Cancer Research|December 3, 2016
Combine and Conquer: Double CTLA-4 and PD-1 Blockade Combined with Whole Tumor Antigen Vaccine Cooperate to Eradicate TumorsKrisztian Homicsko, Jaikumar Duraiswamy, Marie-Agnès Doucey, et al.
Cancer Discovery|May 6, 2014
T-cell and NK-cell infiltration into solid tumors: a key limiting factor for efficacious cancer immunotherapyIgnacio Melero, Ana Rouzaut, Greg T Motz, et al.
Pageof 36

Showing results (51-60 of 355) with videos related to

Sort By:
Pageof 36
RNA Biology|August 19, 2008
Ultraconserved elements: genomics, function and diseaseEirini Baira, Joel Greshock, George Coukos, et al.
Nature Reviews. Cancer|September 15, 2022
Immunobiology of high-grade serous ovarian cancer: lessons for clinical translationLana E Kandalaft, Denarda Dangaj Laniti, George Coukos
Journal of Translational Medicine|August 7, 2012
A phase I clinical trial of adoptive transfer of folate receptor-alpha redirected autologous T cells for recurrent ovarian cancerLana E Kandalaft, Daniel J Powell, George Coukos
International Reviews of Immunology|May 12, 2011
Adjuvants for enhancing the immunogenicity of whole tumor cell vaccinesCheryl Lai-Lai Chiang, Lana E Kandalaft, George Coukos
ACS Sensors|January 10, 2022
High-Throughput Single-Cell TCR-pMHC Dissociation Rate Measurements Performed by an Autonomous Microfluidic Cellular Processing UnitFabien Jammes, Julien Schmidt, George Coukos, et al.
Cancer Cell|January 11, 2022
A roadmap for driving CAR T cells toward the oncogenic immunopeptidomeMelita Irving, Vincent Zoete, Michal Bassani-Sternberg, et al.
Vaccines|September 8, 2015
Whole Tumor Antigen Vaccines: Where Are We?Cheryl Lai-Lai Chiang, George Coukos, Lana E Kandalaft
Annals of Translational Medicine|August 27, 2016
Neoantigen-based cancer immunotherapySara Bobisse, Periklis G Foukas, George Coukos, et al.
Cancer Research|December 3, 2016
Combine and Conquer: Double CTLA-4 and PD-1 Blockade Combined with Whole Tumor Antigen Vaccine Cooperate to Eradicate TumorsKrisztian Homicsko, Jaikumar Duraiswamy, Marie-Agnès Doucey, et al.
Cancer Discovery|May 6, 2014
T-cell and NK-cell infiltration into solid tumors: a key limiting factor for efficacious cancer immunotherapyIgnacio Melero, Ana Rouzaut, Greg T Motz, et al.
Pageof 36